ARTICLE: Colloidal Oatmeal Part I: History, Basic Science, Mechanism of Action, and Clinical Efficacy in the Treatment of Atopic Dermatitis.
Administration, Topical
Anti-Inflammatory Agents
/ pharmacology
Antifungal Agents
/ pharmacology
Antioxidants
/ pharmacology
Avena
/ chemistry
Baths
/ methods
Colloids
Cosmeceuticals
/ pharmacology
Dermatitis, Atopic
/ therapy
Dermatologic Agents
/ pharmacology
Dermatology
/ history
Drug Approval
History, 20th Century
History, Ancient
Humans
Nonprescription Drugs
/ pharmacology
Plant Extracts
/ pharmacology
Skin Cream
/ pharmacology
Treatment Outcome
Journal
Journal of drugs in dermatology : JDD
ISSN: 1545-9616
Titre abrégé: J Drugs Dermatol
Pays: United States
ID NLM: 101160020
Informations de publication
Date de publication:
01 Oct 2020
01 Oct 2020
Historique:
entrez:
7
10
2020
pubmed:
8
10
2020
medline:
8
6
2021
Statut:
ppublish
Résumé
Colloidal oatmeal has a long-standing history in the treatment of dermatologic disease. It is composed of various phytochemicals, which contribute to its wide-ranging function and clinical use. It has various mechanisms of action including direct anti-inflammatory, anti-pruritic, anti-oxidant, anti-fungal, pre-biotic, barrier repair properties, and beneficial effects on skin pH. These have been shown to be of particular benefit in the treatment of atopic dermatitis. In Part 1 of this two-part series, we will explore the history of colloidal oatmeal, basic science, mechanism of action, and clinical efficacy in the treatment of atopic dermatitis. J Drugs Dermatol. 2020;19:10(Suppl):s4-7.
Substances chimiques
Anti-Inflammatory Agents
0
Antifungal Agents
0
Antioxidants
0
Colloids
0
Cosmeceuticals
0
Dermatologic Agents
0
Nonprescription Drugs
0
Plant Extracts
0
Types de publication
Historical Article
Journal Article
Langues
eng
Sous-ensembles de citation
IM